BERWYN, Pa., Nov. 1, 2018 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) announced that it has completed an amended and restated Revolving Credit Facility increasing the size from $850 million to $1.5 billion. The facility, previously due to expire in March 2021, now has a maturity date of October 2023. “AMETEK’s Revolving Credit Facility is a key... Read more
Basel, 01 November 2018 Phase III data showed that Venclexta/Venclyxto plus Gazyva/Gazyvaro reduced the risk of disease worsening or death in people with previously untreated chronic lymphocytic leukaemia with co-morbidities The phase III CLL14 study compared Venclexta/Venclyxto in combination with Gazyva/Gazyvaro to standard-of-care Gazyva/Gazyvaro plus chlorambucil Data will be submitted to health authorities and presented... Read more
PDF Version Senior Financial Leader with Broad Corporate and Biotech Expertise SOUTH SAN FRANCISCO, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Laura M. Clague to the company’s Board of Directors and its audit committee. Clague is Chief Financial Officer of Retrophin, Inc., with more than 30 years of experience as a senior financial executive.... Read more
October 31, 2018 11:45 AM Pacific Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before... Read more
Thermo Fisher Scientific to Present at the Jefferies 2018 London Healthcare Conference on November 14, 2018 WALTHAM, Mass., Oct. 31, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Jefferies 2018 London Healthcare Conference on... Read more
WALTHAM, Mass., Oct. 31, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Jefferies 2018 London Healthcare Conference on Wednesday, November 14, 2018, at 10:40 a.m. (GMT) at the Waldorf Hilton, London, UK. You can... Read more
30 OCT 2018 | DARMSTADT, GERMANY Joint award with manager magazin Barbara Grüner and Sascha Fahl are the first winners Franz-Ulrich Hartl inducted into the Hall of Fame of German Research Darmstadt, Germany, October 30, 2018 – Merck KGaA, Darmstadt, Germany, the vibrant science and technology company, and the German business journal “manager magazine” today presented the... Read more
Cambridge, UK – 30 October 2018: Abcam plc, a global innovator in life science reagents and tools, announced today that it has appointed Cheri Walker, PhD, to the role of Senior Vice President, Corporate Development. Cheri is an accomplished industry professional with over 20 years’ experience in the life sciences tools and diagnostics sector. She... Read more
Q3 2018 results exceed targets as QIAGEN on track to achieve 2018 goals: Net sales of $377.9 million +3.8% reported (+6.5% at constant exchange rates, or CER vs. ~6% CER guidance) EPS of $0.26; adjusted EPS $0.35 ($0.36 CER vs. ~$0.33-0.34 CER guidance) Free cash flow for first nine months of 2018 rises 21% to... Read more
WALTHAM, Mass., Oct. 29, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Dan Shine, senior vice president and president, Analytical Instruments, will present at the Baird 2018 Global Industrial Conference on Wednesday, November 7, 2018, at 12:30 p.m. (CST) at the Four Seasons Hotel, Chicago, Ill. You... Read more